Technology | 2016.01.05
Gene Editing: Bayer and Crispr Therapeutics form CRISPR/Cas9 technology pact - The Biological SCENE
| Xconomy | Gene Editing : Bayer and Crispr Therapeutics form CRISPR/Cas9 technology pact The Biological SCENE Bayer and Crispr Therapeutics have established a joint venture to use CRISPR/Cas9 gene- editing technology to develop therapies to treat blood disorders, blindness, and congenital heart disease. Bayer will sink at least $300 million into R&D over the ... Historic CRISPR Patent Fight Primed To Become Head-To-Head Battle Bayer and CRISPR Therapeutics form JV to develop therapeutics using ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]Bayer-Crispr-Therapeutics.html
